May 6, 2017

Boston BioForum 2017 - CABA10th Annual Conference

Time: 10:00 AM to 6:00 PM on Saturday, May 6, 2017

Location: Boston Marriott Newton, 2345 Commonwealth Ave, Newton, MA 02466

Presented by

Chinese-American BioMedical Association (CABA)


CABA members: FREE; Non-members: $30. On-site membership registration available ($30 annual membership fee due).



Conference Organizing Committee Chair 

Kevin Fang



09:00 - 10:00 am Registration / Social Networking 

10:00 - 10:05 am Opening Remarks, Kevin Fang, Ph.D., Conference Chair, President-Elect, CABA 

10:05 - 10:15 am Introduction of CABA, Eric Shi, Ph.D., President, CABA 


Session I – Novel Therapies for Cancer and Neurological Diseases 

SESSION CHAIR: Lan Cao, Ph.D. and Cindy Yang, MBA. 

10:15 - 10:50 am Samarth Kulkarni, Ph.D., Chief Business Officer, CRISPR Therapeutics. “CRISPR-based Therapeutics: Making it a Reality in Asian Markets” 

10:50 - 11:25 am Ken LéClair, VP, Technical Development and Manufacturing, Editas Medicine. “Development of Cell and Gene-Edited Products” 

11:25-12:00 pm Carmen Bozic, M.D. SVP Global Develop, Biogen. “Innovations in Intrathecal Antisense Oligonucleotide Therapy for Neurological Diseases” 


LUNCH AND VENDOR SHOW: 12:00 - 1:30 pm (Lunch Provided on Site) 



12:45 - 1:05 pm John Yao, Ph.D., Co-founder and CEO, TC Scientific Inc. “A CRO’s View of the Pharma Landscape” hosted by Ellen Fan, MSc 


SESSION II – Global Innovation, Investment, and Entrepreneurship 


1:30 - 2:05 pm Hui Cai, Ph.D., VP of Corporate Alliances and Head of Communications, WuXi AppTec. “Platform and Ecosystem for R&D Transformation” 

2:05 - 2:40 pm James Yang, Ph.D., President and CEO, Abpro-China. “Strategic Partnership for Success in Biologics 

2:40 - 3:15 pm Yongzhong Wang, Ph.D., President of Pharmaceuticals and Executive VP of Simcere Pharmaceutical Group. “Innovations across the Border, a Personal Journey” 

3:15 - 3:50 pm Lynn Yang, MBA, Managing Director, Sequoia Capital. “Sequoia China Healthcare Investment Strategy” 




SESSION III - Global Pharma Trends, CFDA Regulatory Reform and Scientific Advancement in PD-1 Research 

SESSION CHAIRS: Wendy Yang, MBA and Susan Qu, Ph.D., MBA 

4:20 - 4:55 pm Kenneth Kaitin, Ph.D., Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine “The Global Landscape for Pharmaceutical R&D: Current Trends - Future Opportunities” 

4:55 - 5:30 pm XinYu Weng, Ph.D., MBA, First Secretary of the Embassy of the China to the USA. “Overview of CFDA Drug Regulatory Reform” 

5:30 - 6:05 pm Gordon Freeman, Dana-Farber Cancer Institute, Professor, Medicine, Harvard Medical School. "PD-1 Cancer Immunotherapy" 

6:05 - 6:10 pm Closing Remarks

6:10 - 8:30 pm 10th Anniversary Evening Celebration (By Invitation Only)

6:10 - 6:50 pm Key Feature: Former Presidents' Documentary Film

6:50 - 7:50 pm Dinner

7:50 - 8:30 pm Performances

Click here for registration